Company ProfilePremium

Bedoukian Research Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Bedoukian Research Inc. - Consumer Goods showcase

Year Founded & Workforce

1972

Industry

Consumer Goods
Bedoukian Research Inc. logo

Bedoukian Research Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Bedoukian Research Inc. Overview

A three-year employee trend is not publicly disclosed. The aggregator figures suggest growth from about 80 in 2017 to somewhere above 100 by 2025, but the sources use different methods and should not be read as a series.

Bedoukian Research is a small, family-owned US maker of high-impact aroma chemicals, founded in 1972 and based in Danbury, Connecticut. It does not compete with the large flavor and fragrance houses in compounding. It sells single molecules to them and to other formulators: unsaturated aldehydes, leaf-alcohol derivatives, lactones, jasmonoids and similar materials that work at low dose. A second brand, BedoukianBio, applies the same multi-step organic synthesis to insect pheromones and repellent actives. A third activity is custom and toll manufacturing for pharmaceutical, biotech and agrochemical clients. The company's edge is chemistry depth and speed: R&I reports directly to the CEO and sits next to the plant. Its constraints are scale, a single manufacturing site and limited disclosure. Since the death of long-time president Dr. Robert Bedoukian in August 2024, the company has moved to professional management, appointing a non-family CEO in October 2025.


The company's own description. There is no annual report. The closest equivalent is the boilerplate in the 18 May 2026 press release, which describes a family-owned specialty chemical company founded in 1972 and headquartered in Danbury. It supplies aroma chemicals and blends for flavor, fragrance and personal care under the Bedoukian Flavor & Fragrance brand, and provides custom manufacturing for pharmaceutical, biotech and agrochemical clients. The October 2025 CEO announcement adds semiochemicals as a second served industry alongside flavor and fragrance.

Independent characterization. Bedoukian is an upstream ingredient manufacturer. It sits between commodity and fine-chemical feedstock suppliers and the compounders (flavor and fragrance houses) that blend ingredients into finished flavors and perfumes for consumer goods companies. Its catalog is weighted to "high-impact" molecules, meaning materials used at fractions of a percent in a formula. The 2026 featured fragrance list shows recommended odor evaluation levels of 0.1% to 10%. This positions the company in low-volume, high-value specialties, where purity, isomer control and reliable supply matter more than tonnage.

Revenue model. All evidence points to product sales (merchant sale of molecules by the kilogram) plus fee-based custom synthesis and toll processing. There is no indication of subscription or licensing revenue. Repellent actives are patented and offered as ingredients for others' formulations, which could involve licensing, but no licence terms are disclosed. The revenue mix across flavor, fragrance, pheromones and custom work is not publicly disclosed.

Value chain position.

End-markets. Per the company: food and beverage flavors, fine fragrance, personal care, home care and air care; agricultural, forestry, residential and stored-product pest management through BedoukianBio; and pharmaceutical, biotech, agrochemical and specialty chemical custom manufacturing.

Catalog size: conflicting figures. Sources differ and the discrepancy should be noted, not resolved by guesswork:

The differences probably reflect definitions (all catalog items versus actively promoted molecules), but this is not confirmed.

Strategy

There is no annual report or investor day. Strategy has to be read from press releases and management statements. Themes are paraphrased.

Financial targets and guidance. None are published. Cost programs, capex plans and growth targets are not publicly disclosed.

Products & Services

Pricing is by quotation and is not published. Launch years for individual molecules are generally not disclosed. Two historic exceptions are known: leaf alcohol chemistry dating to 1963, and Lactone of Cis Jasmone and cis-3-hexenyl salicylate supplied by 1973.

Fragrance ingredients: 2026 Featured Fragrance list

Product (BRI no.)Chemical identityCASOdor characterSuggested evaluation level
HYDROFLEUR (279-SUS)6-Hydroxy-2,6-dimethylheptanal62439-42-3Fresh, watery-ozonic with raspberry and melon10%
Tridecanal (287)Tridecanal10486-19-8Waxy citrus, grapefruit hint1%
PARMAVERT (310)2-Nonynal dimethyl acetal13257-44-8Green floral, violet leaf1%
e,z-2,6-Nonadien-1-al diethyl acetal (317)As named67674-36-6Violet and melon0.1%
ORRISOL (330-SUS)3,6-Nonadienol76649-25-7Green cucumber, orris, honeydew5%
3,6-Nonadien-1-yl acetate (338)As named76649-26-8Soft fresh green1%
VALENCIAL FCC (356-SUS)trans-2-Dodecenal20407-84-5Aldehydic orange peel1%
CANTALAL (359)cis-5-Octenal41547-22-2Watermelon with citrus0.1%
CARDAMOM ALDEHYDE FCC (381)cis-4-Decenal21662-09-9Spicy aldehydic citrus, crushed cardamom1%
TANGELAL (387)cis-4-Dodecenal21944-98-9Tangerine and orange peel1%
APRITONE (410)2-(3,7-Dimethyl-2,6-octadienyl)cyclopentanone68133-79-9Apricot and peach with jasmine10%
LACTONE OF CIS JASMONE (411-SUS)5-(3Z)-3-Hexenyldihydro-5-methyl-2(3H)-furanone70851-61-5Creamy jasmine, white floral10%
GUAVANATE (493)Methyl (Z)-5-octenoate41654-15-3Ripe tropical, sweet green fruit1%
CEREZOATE (512)Ethyl 2-methyl-3-pentenoate1617-23-8Juicy fruit, black cherry1%
Methyl Anjoulate (535)Methyl (4E)-4,7-octadienoate189440-77-5Green sweet pear5%
2-Octen-4-one (614)As named4643-27-0Green fruity, pineapple and berry1%
VIONIL 10% in DPG (640DPG)2,6-NonadienenitrileMixtureCucumber, violet leaf, orris1%
NUEZATE (728)Ethyl 3-methyl-2-oxopentanoate26516-27-8Gourmand walnut and hazelnut, maple1%
TERRASOL FCC (818-SUS)See note18368-91-7Earthy, woody, camphoraceous, patchouli-like1%
Ethyl vanillin propylene glycol acetal (831)As named68527-76-4Vanilla with clove-like spice5%
3-Methyl-2,4-nonanedione (841)As named113486-29-6Anisic, herbal green, lactonic0.1%
LAVENDER ALDEHYDE FCC (857-SUS)2-Isopropyl-5-methyl-2-hexenal35158-25-9Herbaceous lavender, cocoa, bergamot1%
LIMEDIENE (962)Methyl cyclohexadiene30640-46-1Diffusive lemon-lime top note0.1%
FRUITALEUR (9840)Ethyl 2-methyl-3-pentenoate1617-23-8Tropical fruit, pear and pineapple1%

Source: company "2026 Fragrance Molecule Reference" page (last modified 21 August 2026). The company says the list is curated yearly by leadership, sales and R&D. Odor descriptions are paraphrased.

Flavor ingredients

The company publishes a parallel Featured Flavor list and a Flavor i-Catalog. Site metadata names the following materials in connection with the featured lists: Lavender Aldehyde, Terrasol, Nuezate, Cerezoate, Guavanate, Decadionate, Jasmone, Apritone, decanal, Tangelal, Cardamom Aldehyde, Valencial, Orrisol, 3-methyl-2,4-nonanedione, methyltridecanal, heptanal and spilanthol. Several carry "FCC" grade labels, indicating food-grade specification. The company demonstrates flavor materials in water and on blotter (September 2026 news post).

Sustainable ingredients ("-SUS" grades)

Grades with the "-SUS" suffix (279-SUS, 330-SUS, 356-SUS, 411-SUS, 818-SUS, 857-SUS, and 885-SUS and 894-SUS referenced in a 2023 newsletter) form the Sustainable Ingredients range.

BedoukianBio: pheromones and semiochemicals

OfferingDescriptionTarget customerSource
Technical-grade insect pheromonesActive ingredients for monitoring, mass trapping and mating disruption in agriculture, forestry, residential and storage settings; about 50 pheromones cited c. 2023Pheromone product formulators, crop protection companiesTrade press; BedoukianBio
Bed bug surface repellent activePatented, DEET-free, food-grade active; company cites a 99% reduction in bed bug feeding in simulated bedroom tests and activity against cockroaches, scorpions, spiders and ants; sold as an ingredient, not a finished productPest-control product formulatorsPest Management Professional magazine
Biting arthropod repellentsPatent families on control and repellency of biting arthropods and synergistic formulationsRepellent formulatorsPatent records
Stink bug repellent candidatesEight candidate repellents supplied for Virginia Tech testing on brown marmorated stink bug (2017)Research stageResearch presentation
TrademarksCLOAK & SCATTER (2007, insect lure/repellent); PHEROTRAK (2024, pheromone-related)—IPqwery

The company says it holds a leading number of US registrations in EPA's pesticide product system for this category.

Services

ServiceDescriptionSource
Custom productsCustom synthesis of molecules to customer specificationCompany website
Toll processing / custom manufacturingContract manufacture for pharmaceutical, biotech, agrochemical and specialty chemical clientsCompany press release, May 2026
Applications Lab demonstrationsMaterials shown neat, in accord and in finished application; with/without comparisons and cost-in-useCompany news post, Sept 2026
i-CatalogsOnline fragrance and flavor catalogs searchable by character, application and stabilityCompany website

Financial Narrative

Bedoukian publishes no financial statements. No audited revenue, profit, balance sheet or cash flow figure exists in the public domain. The tables below keep the requested structure with blank cells. Nothing is estimated.

Income statement (blank = not publicly disclosed)

Balance sheet (blank = not publicly disclosed)

Cash flow and ratios (blank = not publicly disclosed)

What can be said about scale.

Commentary. The aggregator estimate and the headcount conflict. Revenue per employee in specialty aroma chemicals rarely supports hundreds of millions of dollars from about 126 people. Both data points are reported here and the discrepancy is unresolved. Any revenue figure used in downstream analysis should come from a paid private-company database or direct inquiry, and be labelled as an estimate. The one qualitative margin signal on record is the R&I director's May 2026 statement that a new synthesis route for a strategically important product, now in scale-up, should bring a meaningful margin increase.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Business Lines

Business lineBrandContents

Flavor and fragrance ingredients

Bedoukian Flavor & Fragrance

Aroma chemicals and blends for flavor, fragrance and personal care; featured ingredient lists; "-SUS" sustainable grades

Pheromones and semiochemicals

BedoukianBio

Technical-grade pheromones and semiochemicals for monitoring, mass trapping, mating disruption and repellency; patented repellent actives

Custom manufacturing and toll processing

Bedoukian (Custom Products; Toll Processing)

Contract synthesis for pharma, biotech, agrochemical and specialty chemical clients

Group Entities

EntityLocationRoleSource

Bedoukian Research, Inc.

Danbury, Connecticut

Parent; manufacturing, R&I, Americas sales

Company website

Bedoukian Research Switzerland GmbH

Switzerland

Sales for Europe, Africa and the Middle East

Company contact pages

Bedoukian Research Singapore Pte Ltd

Singapore

Sales for India, China, Japan, the rest of Asia, Australia and New Zealand

Company contact pages

Financial Analysis

IndicatorValueSourceReliability

Sales in 1994

First month above USD 1 million, implying annualized sales of roughly USD 10–12 million at that time

Company timeline

Company-stated milestone; the annualization is an inference

Headcount

About 80 (2017); 126 (2025 profile)

Senator Murphy release; PitchBook

Moderate

Third-party revenue estimate

"Mid hundreds of millions"

LeadIQ

Low. This is a modelled aggregator figure and is hard to reconcile with a workforce of roughly 100–130 at a single plant

EPA penalty

USD 671,899 paid under a 2025 settlement

EPA EAB Final Order

High; the only hard dollar figure on record for the period

Territory Details

TerritoryCoverage modelEntity or partner

North and South America

Direct sales

Bedoukian Research, Inc.

Europe, Africa, Turkey, UAE and Middle East

Direct sales

Bedoukian Research Switzerland GmbH

India, China, Taiwan, Japan, Korea, Southeast Asia, Australia, New Zealand

Direct sales plus distributors

Bedoukian Research Singapore Pte Ltd

Regional distribution

Distributors attending the 2026 summit: BLH, Ashapura, Zoteq, Taytonn, Yinca and Stort

Company news post, Sept 2026

Capital Markets

ItemStatus

Credit ratings (Moody's, S&P, Fitch)

None found

Outside investors

None known

Analyst Conclusions

Guidance and consensus. There is no management guidance and no analyst consensus. The only forward-looking statements on record are qualitative: a growth and innovation phase under the new CEO, a 2027 commercial plan built with distributors, and a new process route expected to lift margins.

Bull case

  1. Margin expansion from process innovation. Management has pointed to a meaningful margin gain on a strategically important product, and the new R&I head has four years of plant experience to deliver it.

  2. Professional leadership with relevant experience. A CEO from McCormick's R&I leadership and a separate non-family chair give the company management depth it did not have under a single owner-president.

  3. Two differentiated platforms. High-impact aroma molecules are less exposed to commodity price competition than bulk aroma chemicals, and BedoukianBio gives exposure to biological pest control.

Bear case

  1. Compliance and regulatory drag. The EPA case showed weak controls over new-chemical notifications across six years. Under the settlement, further lapses would be costly, and tighter TSCA practice slows the molecule launches the company depends on.

  2. Scale and concentration. One plant, roughly 126 people and customers that are also competitors leave little room for error, while Chinese producers are taking share from even the largest houses.

  3. Unproven partnerships and thin IP. Fermentation and renewable-route partnerships announced since 2021 have produced no disclosed commercial launch, and the patent estate centers on a deceased inventor.

Catalysts and monitorables (next 12 months)

Analyst verdict

What the record does support is a clear picture of a business in transition.

For five decades the company was run by two generations of chemist-owners who built a respected niche in difficult, high-impact aroma molecules and later added insect pheromones and repellents. That model ended in August 2024 with Robert Bedoukian's death. The family has since chosen professional management: a non-family chair, a CEO recruited from McCormick, and an R&I head promoted from the plant floor with a mandate to tie research to scale-up and margin.

The early signs are sensible. The September 2026 distributor summit shows a more structured commercial approach, and management is talking about margin, pipeline gaps and customer feedback instead of heritage. The 2025 EPA settlement is the main blemish. It revealed weak regulatory controls over several years and cost about USD 0.67 million, but it also forced an environmental management system and independent audits that a company of this size might not otherwise have adopted.

The structural risks remain: one plant, small scale, customers that also compete, and Asian producers pressing on price. The growth options in fermentation, renewable pheromone routes and repellent actives are real but unproven commercially.

For a counterparty, supplier or adviser, Bedoukian is a credible specialist with strong technical standing and a management team that appears open to outside input. For any valuation or credit view, the public record is insufficient. Revenue, margins and leverage must come from the company or a verified private-company data source. The aggregator revenue estimate in circulation conflicts with the headcount and should not be relied on. Ownership intentions are the key unknown to watch.


Source notes and verification flags

FlagDetail
Company typeBrief says public; evidence shows private and family-owned
FinancialsNo audited figures exist publicly; all financial cells left blank
Revenue estimate conflictLeadIQ suggests mid hundreds of millions; headcount of about 126 (PitchBook) makes this doubtful; unresolved
Catalog size conflict300+, 450+50 and 500+ figures cited at different dates
Featured list errorsTERRASOL chemical name and the CEREZOATE/FRUITALEUR CAS duplication on the company page
—First P2 Science agreement (c. 2014); Ardra collaboration (c. 2021); P2 pheromone JDA (c. April 2023)
Roles not re-verifiedCFO and several director-level roles drawn from 2023–2024 sources
Peer dataGivaudan FY2025 verified against its results release; Symrise and IFF FY2024 figures not re-verified
EMS deadline3 November 2025 is derived from the 270-day term, not stated in the order
Market sizesNot sourced; order-of-magnitude only

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure and backgroundSource

Robert Sobel, Ph.D.

Chief Executive Officer

Appointed 20 Oct 2025; over 25 years in scientific and technology leadership; most recently VP Research & Innovation at McCormick

Company press release

Robert Weinstein, Ph.D.

Chair of the Board

Named as Chair in Oct 2025; start date and background not disclosed in sources retrieved

Company press release

Paul Decker

Board member

Listed as board member from Jan 2022

Crunchbase

Jim Zitelli

Chief Financial Officer

—

Company press archive

Krzysztof Swierczek, Ph.D.

Director of Research and Innovation

Joined R&I as a chemist in 2012; Technical Production Manager 2022–2026; named Director 18 May 2026

Company press release

Maha Ali

Applications Lab Director

Quoted Sept 2026

Company news post

David Bedoukian

VP of Sales (as listed May 2024)

Third generation; joined 2006

Wiza; company timeline

Matt Bedoukian

Role not confirmed

Third generation; joined 2006

Company timeline

Clarisa Braier

Sales, North and South America

Joined Jan 2024

Company press release

Eleanor Badhe

Sales, Europe, Africa, Middle East

Bedoukian Research Switzerland GmbH

Company contact pages

Elvin Lim

Sales, Asia-Pacific

Bedoukian Research Singapore Pte Ltd

Company contact pages

Executive Leadership Team

NameRolePeriod

Dr. Paul Bedoukian

Founder

1972 until his death (FMA award given posthumously in 2002)

Dr. Robert H. Bedoukian

President

1986 to 30 August 2024; BS chemical engineering, Tufts (1970); PhD organic chemistry, Purdue (1975); founder of BedoukianBio

Competitive Landscape

Key Competitors

CompetitorTypeRelevance to Bedoukian

Givaudan (Fragrance Ingredients)

Listed, Switzerland

Customer and competitor; captive and merchant aroma molecules

dsm-firmenich

Listed, Switzerland/Netherlands

Customer and competitor; large ingredients division

IFF

Listed, USA

Customer and competitor

Symrise

Listed, Germany

Customer and competitor; strong aroma molecules business

BASF Aroma Ingredients

Division of listed group

Large-volume aroma chemicals

Takasago

Listed, Japan

Specialty aroma chemicals, chiral chemistry

Zeon Corporation

Listed, Japan

Leaf alcohol and green-note chemistry, overlapping Bedoukian's heritage class

Privi Speciality Chemicals

Listed, India

Cost-competitive aroma chemicals

Eternis Fine Chemicals

Private, India

Aroma chemicals at scale

Vigon International (Azelis)

Distributor/manufacturer, USA

US specialty flavor and fragrance ingredients

Axxence Aromatic

Private, Germany

Natural aroma chemicals; named as a competitor by CB Insights

Penta Manufacturing; Advanced Biotech

Private, USA

US specialty and natural aroma chemicals

Shin-Etsu Chemical

Listed, Japan

Major pheromone active producer

Suterra (Wonderful Company)

Private, USA

Mating disruption products

Provivi

Private, USA

Lower-cost pheromone synthesis

ISCA

Private, USA

Semiochemical formulations

Russell IPM

Private, UK

Pheromone and trapping products

Peer Comparison FY2025

MetricBedoukian ResearchGivaudan (FY2025)——

Revenue

—

CHF 7,472 M

approx. EUR 5.0 bn

approx. USD 11.5 bn

Growth

—

5.1% like-for-like

approx. 8.7% organic

approx. 6% currency-neutral comparable

EBITDA margin

—

23.4% (24.2% comparable)

approx. 20.7%

approx. 19% (adjusted operating EBITDA)

Employees

approx. 126 (PitchBook)

———

“—” = not publicly disclosed.

Recent Developments

The register is not padded.

Company Snapshot

1972

Founded

Connecticut, US

Headquarters

SWOT Analysis

Strengths

  • Continuous operation since 1972 with chemistry leadership going back to the first commercial leaf alcohol in 1963 (company timeline).
  • A portfolio of over 300 promoted molecules, many with proprietary trade names and FCC grades (company releases; 2026 featured list).
  • R&I reports directly to the CEO and sits beside the plant, shortening lab-to-production cycles (May 2026 release).
  • Applications Lab, perfumer and flavorists able to run eight demonstration sessions across more than 50 applications in one week (Sept 2026 post).
  • Sales entities in three countries plus at least six distributor groups (contact pages; Sept 2026 post).
  • A second growth platform in semiochemicals, backed by granted patents such as US 10,703,705 B2.
  • Long-standing industry standing: RIFM board seat 1989–2022 and FCA involvement since 1995.

Weaknesses

  • All known manufacturing is at one Danbury facility (21 Finance Drive and 27 Augusta Drive, per EPA).
  • EPA alleged repeated manufacture of five new chemical substances without required TSCA filings between 2018 and 2023, and inaccurate toxic release reports for 2018–2021 (EPA Consent Agreement).
  • A USD 671,899 penalty and mandated external audits (EAB Final Order, Feb 2025).
  • Roughly 14 months between the president's death and a permanent CEO, with interim arrangements undisclosed.
  • Repellent patents name a single inventor who has died; the latest listed patent dates from 2022 (patent records; IPqwery).
  • No published financials, which limits the confidence of lenders, partners and large customers doing supplier risk reviews.
  • Inconsistent product data on the company's own featured list page (duplicate chemical name and CAS entries).

Opportunities

  • A new process route in scale-up with a stated meaningful margin gain (May 2026 release).
  • Precision fermentation supply through Inscripta, announced July 2023.
  • Renewable-feedstock pheromone routes with P2 Science.
  • Distributor feedback identifying catalog gaps to steer the R&I pipeline (Sept 2026 post).
  • Structural pest control: a DEET-free, food-grade bed bug repellent active with a cited 99% feeding reduction in simulated tests (trade press).
  • A CEO with large-company R&I experience from McCormick, which may open flavor-side relationships (Oct 2025 release).
  • Custom manufacturing for pharma, biotech and agrochemical clients seeking US-based capacity (company description; SOCMA membership).

Threats

  • Chinese producers taking share in fragrance ingredients, as Givaudan reported for 2025.
  • Customers that are also competitors can bring molecules in-house.
  • TSCA new-chemical requirements slow and raise the cost of launching novel molecules; further violations would carry stipulated penalties under the 2025 agreement.
  • Tariff and input-cost volatility, flagged by Givaudan in 2025.
  • An incident or shutdown at the single plant would interrupt most supply.
  • Fragrance safety standards (IFRA/RIFM) can restrict individual molecules; the company no longer holds the RIFM board seat it had until 2022.
  • Family ownership after the loss of the long-time owner-leader creates uncertainty about long-term control, although no change has been reported.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
14–17 Jan 2025Consent agreement with EPA signed (14 Jan) and filed (17 Jan)Context: settlement of TSCA and EPCRA allegations
6 Feb 2025EPA Environmental Appeals Board ratifies settlement; USD 671,899 civil penaltyLargest known regulatory event in company history
12 Mar 2025Exhibits at FAFAI 2025 (India) with distributorsIndia market development
17–19 Mar 2025Food Ingredients China with distributor ZoteqChina flavor market
26 Mar 2025Flavourtalk 2025, LondonEuropean flavor customers
8 May 2025Chemical Sources Association New Jersey RoundtableCore US flavorist audience
June 2025SIMPPAR, ParisEuropean perfumery raw materials show
20 Oct 2025Robert Sobel, Ph.D., appointed CEOFirst non-family chief executive; succession resolved about 14 months after the president's death
3 Nov 2025Date by which the environmental management system was due under the settlement (270 days from the order; derived)Completion status not publicly disclosed
19 Nov 2025SOCMA announces Bedoukian as a 2025 manufacturer memberAlignment with specialty chemical manufacturing peers
Jan–Apr 2026Hiring in customer service and logistics managementOperational build-out (ZoomInfo)
Undated, 2025–2026Search for a Director of Research & Development reportedPreceded the internal R&I appointment (ZoomInfo)
Early 20262026 Featured Fragrance and Flavor lists publishedAnnual promotional cycle
UndatedBedoukianBio bed bug repellent active featured in Pest Management ProfessionalPush into structural pest control formulators
11 May 2026Trade press reports plans for SIMPPAR and the World Perfumery CongressMarketing of 2026 featured list
18 May 2026Dr. Krzysztof Swierczek named Director of R&IInternal promotion; manufacturing-led R&I agenda
26–27 May 2026SIMPPAR, GrassePlanned participation per trade press
22–25 June 2026World Perfumery Congress, Monterey, CaliforniaPlanned participation per trade press
21 Aug 2026Featured Fragrance reference page updatedCatalog maintenance
14–18 Sept 2026Global Distributor Summit, Danbury: six distributor groups, eight Applications Lab sessions, over 50 applications, plant tours, 2027 planningStrongest evidence of the new CEO's commercial approach

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.